(DOX) Amdocs - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: GB0022569080
DOX: Cloud, Software, Consulting, AI, Telecom, Services
Amdocs Limited (NASDAQ:DOX) is a global leader in providing software and services tailored for communications, entertainment, and media service providers. The company excels in offering comprehensive solutions for billing, customer management, and digital transformation. Amdocs serves a diverse range of clients, including telecom operators, media companies, and pay-TV providers. Their innovative platforms include CES24, which leverages GenAI for enhanced customer experiences, Subscription Marketplace for diverse digital services, connectX for cloud-native telecom solutions, and eSIM Cloud for seamless connectivity management. Additionally, Amdocs provides an array of services such as consulting, cloud integration, network deployment, and AI-driven managed services. Headquartered in Saint Louis, Missouri, Amdocs was founded in 1982 and is renowned for its commitment to advancing telecom solutions through cloud-native technologies and AI innovations.
Looking ahead, the technical indicators suggest that DOX may experience a period of consolidation over the next three months. The stock is trading slightly below its 20-day and 50-day moving averages, indicating potential short-term weakness. However, the proximity to the 200-day moving average suggests a support level. The Average True Range (ATR) of 2.38 indicates manageable volatility. From a fundamental perspective, while the current P/E ratio is elevated at 19.42, the forward P/E of 11.83 signals anticipated earnings growth. The price-to-sales ratio of 1.96 aligns well with industry standards, and a return on equity of 14.96% reflects strong profitability. Considering these factors, DOX is expected to navigate within a range of $80 to $90 over the next quarter, with a potential upward trajectory driven by improving valuations and positive market sentiment.
Additional Sources for DOX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DOX Stock Overview
Market Cap in USD | 9,534m |
Sector | Technology |
Industry | Software - Infrastructure |
GiC Sub-Industry | IT Consulting & Other Services |
IPO / Inception | 1998-06-19 |
DOX Stock Ratings
Growth Rating | 59.0 |
Fundamental | 58.3 |
Dividend Rating | 65.8 |
Rel. Strength | -3.26 |
Analysts | 4.71/5 |
Fair Price Momentum | 85.39 USD |
Fair Price DCF | 121.60 USD |
DOX Dividends
Dividend Yield 12m | 2.30% |
Yield on Cost 5y | 3.46% |
Annual Growth 5y | 7.87% |
Payout Consistency | 99.2% |
DOX Growth Ratios
Growth Correlation 3m | -19.5% |
Growth Correlation 12m | 65.5% |
Growth Correlation 5y | 82.7% |
CAGR 5y | 8.64% |
CAGR/Max DD 5y | 0.37 |
Sharpe Ratio 12m | 0.38 |
Alpha | -4.52 |
Beta | 0.472 |
Volatility | 19.46% |
Current Volume | 478.6k |
Average Volume 20d | 716.3k |
As of April 26, 2025, the stock is trading at USD 86.01 with a total of 478,566 shares traded.
Over the past week, the price has changed by +4.75%, over one month by -4.32%, over three months by -0.23% and over the past year by +2.77%.
Partly, yes. Based on ValueRay Fundamental Analyses, Amdocs (NASDAQ:DOX) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.27 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOX as of April 2025 is 85.39. This means that DOX is currently overvalued and has a potential downside of -0.72%.
Amdocs has received a consensus analysts rating of 4.71. Therefor, it is recommend to buy DOX.
- Strong Buy: 5
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, DOX Amdocs will be worth about 93.4 in April 2026. The stock is currently trading at 86.01. This means that the stock has a potential upside of +8.53%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 101.6 | 18.1% |
Analysts Target Price | 102.1 | 18.7% |
ValueRay Target Price | 93.4 | 8.5% |